How I Do It: Considering lung transplantation for patients with COVID-19.
How I Do It: Considering lung transplantation for patients with COVID-19 – CHEST Related: Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countries Report: Lung transplantation for 3 patients with severe COVID-19
The post How I Do It: Considering lung transplantation for patients with COVID-19. appeared first on Links Medicus.
COVID vaccines protect against Delta, but their effectiveness wanes.
COVID vaccines protect against Delta, but their effectiveness wanes – Nature Original study: [Preprint] Pfizer vaccine effectiveness against Delta declines faster than AstraZeneca, both offering the same protection after 4 months.
The post COVID vaccines protect against Delta, but their effectiveness wanes. appeared first on Links Medicus.
How will Delta evolve? Here’s what the theory tells us.
How will Delta evolve? Here’s what the theory tells us – The Conversation
The post How will Delta evolve? Here’s what the theory tells us. appeared first on Links Medicus.
Opinion | The FDA really did have to take this long – “If vaccine approval feels maddeningly scrupulous, that’s because the alternative is worse”.
The FDA Really Did Have to Take This Long – The Atlantic
The post Opinion | The FDA really did have to take this long – “If vaccine approval feels maddeningly scrupulous, that’s because the alternative is worse”. appeared first on Links Medicus.
Covid-19 booster vaccines: What we know and who’s doing what.
Covid-19 booster vaccines: What we know and who’s doing what – The BMJ
The post Covid-19 booster vaccines: What we know and who’s doing what. appeared first on Links Medicus.
[Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19.
RCT: Effect of Early Treatment with Fluvoxamine on Risk of Emergency Care and Hospitalization Among Patients with COVID-19 – Together Clinical Trials Related: Opinion | Could this be our first effective, inexpensive, widely available outpatient treatment for COVID-19? (It’s fluvoxamine). Preliminary study shows fluvoxamine may reduce clinical deterioration in outpatients with symptomatic COVID-19 Commentary […]
The post [Preprint] RCT: Fluvoxamine reduced the risk for ER visits and hospitalization among patients with Covid-19. appeared first on Links Medicus.
Lab study shows a heterologous AstraZeneca + Pfizer immunization strategy provides stronger immunogenicity against Covid compared to homologous AZ + AZ or Pfizer + Pfizer strategies.
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study – The Lancet Respiratory Medicine Invited Commentary: Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19 Related: Lab study shows heterologous AstraZeneca/Pfizer vaccination produces strong immune response against SARS-CoV-2 Delta variant. RCT: Safety and immunogenicity of heterologous […]
The post Lab study shows a heterologous AstraZeneca + Pfizer immunization strategy provides stronger immunogenicity against Covid compared to homologous AZ + AZ or Pfizer + Pfizer strategies. appeared first on Links Medicus.
Study Commentaries: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial.
Commentary 1: JC: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial – St Emlyn’s Commentary 2: An adaptive randomized controlled trial of non-invasive respiratory strategies in acute respiratory failure patients with COVID-19 – The Bottom Line Original study: [Preprint] RCT: non-invasive respiratory strategies in acute respiratory failure in patients with COVID-19 – CPAP […]
The post Study Commentaries: Non-invasive ventilation for COVID 19 patients. The Recovery RS trial. appeared first on Links Medicus.
Among patients receiving mRNA vaccines, clinically significant symptoms were more frequent following dose 2, following dose 1 in patients with previous SARS-CoV-2 infection, and in those who received the Moderna vaccine.
Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers – JAMA Internal Medicine Commentary on Twitter New @JAMA_current paper says @moderna_Tx caused 2.3x the number of "significant" symptoms compared to @pfizer in a sample of 950 people. Moderna also produced more antibodies. Raising the […]
The post Among patients receiving mRNA vaccines, clinically significant symptoms were more frequent following dose 2, following dose 1 in patients with previous SARS-CoV-2 infection, and in those who received the Moderna vaccine. appeared first on Links Medicus.
Evidence mounts that people with breakthrough infections can spread Delta easily.
Evidence mounts that people with breakthrough infections can spread Delta easily – National Geographic Original study: Shedding of Infectious SARS-CoV-2 Despite Vaccination when the Delta Variant is Prevalent – Wisconsin, July 2021 – medRxiv Commentary on Twitter The evidence that supports Delta breakthrough infections ability to spread (and why fully vaccinated people need to […]
The post Evidence mounts that people with breakthrough infections can spread Delta easily. appeared first on Links Medicus.